GLP1R and alkaline phosphatase measurement: The median age of patients was 57 years (range: 14–99 years) in our pharmacovigilance analysis and 60 years (range: 27–77 years) for the cases of GLP-1 RAs-induced AP published in the case reports, which is in line with earlier observational studies on drug-induced AP (Gagnon et al., 2020; Chadalavada et al., 2020).